Update on the effectiveness of COVID-19 vaccines on different variants of SARS-CoV-2
It has been more than three years since the first emergence of coronavirus disease 2019
(COVID-19) and millions of lives have been taken to date. Like most pandemics caused by …
(COVID-19) and millions of lives have been taken to date. Like most pandemics caused by …
[HTML][HTML] Efficacy of mRNA, adenoviral vector, and perfusion protein COVID-19 vaccines
Abstract Coronavirus disease 2019 (COVID-19) has a devastating impact on global
populations triggered by a highly infectious viral sickness, produced by the severe acute …
populations triggered by a highly infectious viral sickness, produced by the severe acute …
An intranasal vaccine comprising SARS-CoV-2 spike receptor-binding domain protein entrapped in mannose-conjugated chitosan nanoparticle provides protection in …
K Tabynov, M Solomadin, N Turebekov, M Babayeva… - Scientific reports, 2023 - nature.com
We developed a novel intranasal SARS-CoV-2 subunit vaccine called NARUVAX-C19/Nano
based on the spike protein receptor-binding domain (RBD) entrapped in mannose …
based on the spike protein receptor-binding domain (RBD) entrapped in mannose …
First approval of the protein-based adjuvanted nuvaxovid (NVX-CoV2373) novavax vaccine for SARS-CoV-2 could increase vaccine uptake and provide immune …
DV Parums - … science monitor: international medical journal of …, 2022 - pmc.ncbi.nlm.nih.gov
The Nuvaxovid™(NVX-CoV2373) Novavax vaccine is a recombinant spike (S) protein
nanoparticle vaccine combined with the Matrix-M adjuvant. On December 20, 2021, the …
nanoparticle vaccine combined with the Matrix-M adjuvant. On December 20, 2021, the …
Neutralizing antibodies to SARS‐CoV‐2 variants of concern including Delta and Omicron in subjects receiving mRNA‐1273, BNT162b2, and Ad26. COV2. S vaccines
SARS‐CoV‐2 vaccines have contributed to the control of COVID‐19 in some parts of the
world. However, the constant emergence of variants of concern (VOCs) challenges the …
world. However, the constant emergence of variants of concern (VOCs) challenges the …
A review on immunological responses to SARS-CoV-2 and various COVID-19 vaccine regimens
S Upreti, M Samant - Pharmaceutical Research, 2022 - Springer
The transmission of SARS-CoV-2 has caused serious health crises globally. So far, 7
vaccines that are already being assessed in Phase IV clinical trials are, Comirnaty/Pfizer; …
vaccines that are already being assessed in Phase IV clinical trials are, Comirnaty/Pfizer; …
SARS-CoV-2: Pathogenesis, therapeutics, variants, and vaccines
X Li, Z Mi, Z Liu, P Rong - Frontiers in Microbiology, 2024 - frontiersin.org
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), emerged in December 2019 with staggering economic fallout …
coronavirus 2 (SARS-CoV-2), emerged in December 2019 with staggering economic fallout …
Vaccines for the Elderly and Vaccination Programs in Europe and the United States
The share of the elderly population is growing worldwide as life expectancy increases.
Immunosenescence and comorbidities increase infectious diseases' morbidity and mortality …
Immunosenescence and comorbidities increase infectious diseases' morbidity and mortality …
[HTML][HTML] From Immunogen to COVID-19 vaccines: Prospects for the post-pandemic era
G Miao, Z Chen, H Cao, W Wu, X Chu, H Liu… - Biomedicine & …, 2023 - Elsevier
The COVID-19 pandemic has affected millions of people and posed an unprecedented
burden on healthcare systems and economies worldwide since the outbreak of the COVID …
burden on healthcare systems and economies worldwide since the outbreak of the COVID …
[HTML][HTML] Real-world effectiveness of mix-and-match vaccine regimens against SARS-CoV-2 Delta variant in Thailand: a nationwide test-negative matched case-control …
R Suphanchaimat, N Nittayasoot, C Jiraphongsa… - Vaccines, 2022 - mdpi.com
The objective of this study is to explore the real-world effectiveness of various vaccine
regimens to tackle the epidemic of severe acute respiratory syndrome coronavirus 2 (SARS …
regimens to tackle the epidemic of severe acute respiratory syndrome coronavirus 2 (SARS …